** p<0.01 obese Vs control; p<0.01 NIDM Vs Control, ¥p<0.01 obese Vs NIDM; NS: Not Significant. (NIDM, Non Insulin-dependent Diabetes Mellitus). Metabolic characteristics of lean, obese and type 2 dia
Background: Combination therapy with immune checkpoint inhibitors (ICIs) has been widely used for clinical treatment in recent years, which has a better survival benefit. However, not all patients can
No correlation was found among CD133+ EVs and ischemia time, introduction of calcineurin inhibitors (CNI), HLA mismatches, and pre-transplant diuresis. Data are expressed are median [min-max], p* = Ma